PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 3,245.00
+120.00 (3.84%)
At close: Aug 24, 2026
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 73.38 billion as of August 24, 2026. Its market cap has decreased by -11.25% in one year.
Market Cap
73.38B
Enterprise Value
78.72B
Revenue
171.66B
Ranking
n/a
PE Ratio
623.16
Stock Price
3,245.00
ChartMarket Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 73.38B, an increase of 573.69%. That is a compound annual growth rate of 6.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 73.38B | -19.41% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.72T |
| Celltrion | 44.10T |
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 8.94T |
| CKD Bio | 75.43B |
| Prestige BioPharma | 72.96B |
| Ildong Holdings | 72.16B |
| Ray Co., Ltd. | 70.85B |